Literature DB >> 394667

Genetic susceptibility to cholera.

M M Levine, D R Nalin, M B Rennels, R B Hornick, S Sotman, G Van Blerk, T P Hughes, S O'Donnell, D Barua.   

Abstract

In the course of studies of immunity to experimental cholera in man, 10(5) or 10(6) Vibrio cholerae were given to 66 college students and other community volunteers under quarantine in an isolation ward. HLA antigen and blood group determinations were carried out to test the hypothesis that severity of clinical cholera is dependent in part upon genetically-determined host susceptibility. Fifty-five volunteers developed diarrhoea; 38 had mild illness and 17 had severe cholera (stool volume greater than or equal to 5.0 litres). HLA antigens were found in similar frequency in volunteers with severe, mild or no diarrhoea; antigen A1, A2, A3 and B7 were most common. Blood group O, however, was found in 64% of persons with severe cholera versus 36-38% of volunteers with mild or absent illness. Thus, while no correlation was found between HLA type and severity of cholera, these results do support the claims of other investigators that blood group O is found more frequently in patients with severe cholera than in the normal population.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 394667     DOI: 10.1080/03014467900003751

Source DB:  PubMed          Journal:  Ann Hum Biol        ISSN: 0301-4460            Impact factor:   1.533


  24 in total

Review 1.  Prevention and self-treatment of traveler's diarrhea.

Authors:  David J Diemert
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

2.  An overview of VaxchoraTM, a live attenuated oral cholera vaccine.

Authors:  Tarun Saluja; Vijayalaxmi V Mogasale; Jean-Louis Excler; Jerome H Kim; Vittal Mogasale
Journal:  Hum Vaccin Immunother       Date:  2019-09-20       Impact factor: 3.452

3.  Binding of cholera toxin to pig intestinal mucosa glycosphingolipids: relationship with the ABO blood group system.

Authors:  F R Bennun; G A Roth; C G Monferran; F A Cumar
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

4.  Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.

Authors:  M M Levine; J B Kaper; D Herrington; G Losonsky; J G Morris; M L Clements; R E Black; B Tall; R Hall
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

Review 5.  Relationship between infectious diseases and human blood type.

Authors:  S A Berger; N A Young; S C Edberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

Review 6.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 7.  Modeling cholera outbreaks.

Authors:  Dennis L Chao; Ira M Longini; J Glenn Morris
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

8.  The utility of human challenge studies in vaccine development: lessons learned from cholera.

Authors:  Debbie-Ann T Shirley; Monica A McArthur
Journal:  Vaccine (Auckl)       Date:  2011-10

9.  The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.

Authors:  Muhammad Asaduzzaman; Edward T Ryan; Manohar John; Long Hang; Ashraful I Khan; A S G Faruque; Ronald K Taylor; Stephen B Calderwood; Firdausi Qadri
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Familial aggregation of Vibrio cholerae-associated infection in Matlab, Bangladesh.

Authors:  Kazi Mizanur Rahman; Priya Duggal; Jason B Harris; Sajal Kumar Saha; Peter Kim Streatfield; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri; Mohammad Yunus; Regina C LaRocque
Journal:  J Health Popul Nutr       Date:  2009-12       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.